Here are what the editors at HealthDay consider to be the most important developments in Nephrology for January 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Risk of Diabetes Down With HCV SVR in HIV/HCV Coinfection
FRIDAY, Jan. 27, 2017 (HealthDay News) — In patients co-infected with HIV and hepatitis C virus (HCV), eradication of HCV is associated with a reduction in the risk of diabetes mellitus, according to a study published online Jan. 21 in Hepatology.
Full Text (subscription or payment may be required)
Nephrologists Often Don’t Treat Depression in Dialysis Patients
FRIDAY, Jan. 27, 2017 (HealthDay News) — Depression is common among kidney failure patients undergoing dialysis, but efforts to get them on antidepressants often fail, according to research published online Jan. 26 in the Clinical Journal of the American Society of Nephrology.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Most PCPs Oppose Complete Repeal of the Affordable Care Act
THURSDAY, Jan. 26, 2017 (HealthDay News) — A majority of primary care doctors oppose full repeal of the Affordable Care Act, according to a perspective piece published online Jan. 25 in the New England Journal of Medicine.
Strategies Presented for Addressing Uncompensated Time
THURSDAY, Jan. 26, 2017 (HealthDay News) — Strategies can be employed to help physicians deal with the increasing burden of uncompensated tasks, according to an article published in Medical Economics.
ACA Has Increased Coverage, Access for Chronically Ill Patients
TUESDAY, Jan. 24, 2017 (HealthDay News) — Millions of Americans with a chronic illness gained health insurance coverage after the Affordable Care Act went into effect in 2010, according to a study published online Jan. 24 in the Annals of Internal Medicine.
Full Text (subscription or payment may be required)
Nadir Platelet Counts Tied to AKI in Pediatric Open-Heart Surgery
MONDAY, Jan. 23, 2017 (HealthDay News) — For pediatric patients undergoing cardiopulmonary bypass (CPB), postoperative nadir platelet counts are associated with the severity of acute kidney injury (AKI), according to a review published online Jan. 18 in Pediatric Anesthesia.
Full Text (subscription or payment may be required)
Obesity Underrepresented in Medical Licensing Exams
FRIDAY, Jan. 20, 2017 (HealthDay News) — The most important concepts of obesity prevention and treatment are not adequately represented on the U.S. Medical Licensing Examination (USMLE) Step examinations, according to a study published recently in Teaching and Learning in Medicine.
Full Text (subscription or payment may be required)
Biomarkers, Clinical Risk Improve Prediction of Renal Function
THURSDAY, Jan. 19, 2017 (HealthDay News) — For patients with type 2 diabetes and chronic kidney disease (CKD), a set of nine molecular biomarkers together with clinical risk factors enhances prediction of renal function loss, according to a study published online Jan. 11 in Diabetes Care.
Full Text (subscription or payment may be required)
Recommendations Developed for Small Renal Mass Management
WEDNESDAY, Jan. 18, 2017 (HealthDay News) — In a clinical practice guideline published online Jan. 16 in the Journal of Clinical Oncology, recommendations are presented for the management of patients with small renal masses (SRMs).
Metabolites Linked to Renal Decline, Time to ESRD in T1DM
WEDNESDAY, Jan. 18, 2017 (HealthDay News) — Serum levels of seven modified metabolites are associated with renal function decline and time to end-stage renal disease (ESRD) among patients with type 1 diabetes (T1D), according to a study published online Jan. 13 in Diabetes Care.
Full Text (subscription or payment may be required)
Physician Excess Charges Create Financial Burden for Patients
TUESDAY, Jan. 17, 2017 (HealthDay News) — Many doctors bill their private-paying patients two, three, even six times more than what Medicare pays for the same services, according to a research letter published in the Jan. 17 issue of the Journal of the American Medical Association.
Full Text (subscription or payment may be required)
Normal Vitamin D Intake Not Linked to Kidney Stone Risk
TUESDAY, Jan. 17, 2017 (HealthDay News) — There is no statistically significant correlation between typical vitamin D intake and incident kidney stones, according to a study published in the February issue of The Journal of Urology.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Excessive FDA Regulation Driving High Drug Prices
WEDNESDAY, Jan. 11, 2017 (HealthDay News) — The excessive regulatory regime at the U.S. Food and Drug Administration is an important driver of high drug prices, and should be curbed to introduce more competition and lower prices, according to a report published online Jan. 5 by the National Center for Policy Analysis.
CDC: Renal Failure From Diabetes Declining in Native Americans
WEDNESDAY, Jan. 11, 2017 (HealthDay News) — Diabetes-related end-stage renal disease among Native American adults fell by more than half over almost 20 years, according to research published in the Jan. 10 early-release issue of the U.S. Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report.
Global Rates of Hypertension on the Rise
WEDNESDAY, Jan. 11, 2017 (HealthDay News) — The global rate of hypertension and prehypertension rose significantly between 1990 and 2015, according to a report published in the Jan. 10 issue of the Journal of the American Medical Association.
Full Text
Editorial (subscription or payment may be required)
Chemo Benefits Patients After Nephroureterectomy in UTUC
FRIDAY, Jan. 6, 2017 (HealthDay News) — For patients undergoing radical nephroureterectomy (RNU) for pT3/T4 and/or pN+ upper tract urothelial carcinoma (UTUC), adjuvant chemotherapy (AC) use is associated with an overall survival benefit, according to a study published online Jan. 3 in the Journal of Clinical Oncology.
Metformin Tied to Better Clinical Outcomes in CKD, CHF, CLD
WEDNESDAY, Jan. 4, 2017 (HealthDay News) — For patients with chronic kidney disease (CKD), congestive heart failure (CHF), or chronic liver disease (CLD) with hepatic impairment, metformin use is associated with improvements in clinical outcomes, according to a review published online Jan. 3 in the Annals of Internal Medicine.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Copyright © 2017 ScoutNews, LLC. All rights reserved.
